Atavistik Bio is a verified, high-potential biotechnology company that recently raised a $120M Series B (approx. $220M total funding) to develop precision allosteric therapeutics. However, the submission itself is of extremely low quality, submitted by an unrelated alias ('CrimsonBlade') with demonstrably false claims (e.g., 'most people have used my product' for a pre-clinical asset). The score reflects the massive verified real-world value and financial traction of the entity, significantly penalized by the fraudulent nature of the submission text.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline